{
    "Trade/Device Name(s)": [
        "VITEK 2 AST-Gram Negative Plazomicin (\u22640.5 - \u226516 \u03bcg/mL)",
        "VITEK\u00ae 2 ASTGN Plazomicin (\u22640.5 - \u226516 \u03bcg/mL)",
        "VITEK 2 AST-GN Plazomicin"
    ],
    "Submitter Information": "bioMerieux, Inc.",
    "510(k) Number": "K223478",
    "Predicate Device Reference 510(k) Number(s)": [
        "K163563"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LON",
        "LTT",
        "LTW"
    ],
    "Summary Letter Date": "February 16, 2023",
    "Summary Letter Received Date": "November 18, 2022",
    "Submission Date": "November 17, 2022",
    "Regulation Number(s)": [
        "21 CFR 866.1645"
    ],
    "Regulation Name(s)": [
        "Fully Automated Short-Term Incubation Cycle Antimicrobial Susceptibility System"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Plazomicin",
        "Escherichia coli",
        "Klebsiella pneumoniae",
        "Enterobacter cloacae",
        "Citrobacter freundii",
        "Citrobacter koseri",
        "Klebsiella (Enterobacter) aerogenes",
        "Klebsiella oxytoca",
        "Proteus vulgaris",
        "Serratia marcescens"
    ],
    "Specimen Type(s)": [
        "Isolated colony of Gram negative bacilli"
    ],
    "Specimen Container(s)": [
        "0.45 - 0.5% saline suspension"
    ],
    "Instrument(s)/Platform(s)": [
        "VITEK 2 System",
        "VITEK 2 Compact System"
    ],
    "Method(s)/Technology(ies)": [
        "Automated quantitative antimicrobial susceptibility test",
        "Microdilution minimum inhibitory concentration (MIC)",
        "Growth Pattern Analysis (GPA)"
    ],
    "Methodologies": [
        "Microdilution",
        "Automated antimicrobial susceptibility testing"
    ],
    "Submission Type(s)": [
        "Susceptibility Card",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for VITEK 2 AST-GN Plazomicin susceptibility card for automated quantitative antimicrobial susceptibility testing of Gram negative bacilli",
    "Indications for Use Summary": "Designed for antimicrobial susceptibility testing of Gram negative bacilli as a laboratory aid in determining in vitro susceptibility to antimicrobial agents using VITEK 2 and VITEK 2 Compact Systems",
    "fda_folder": "Microbiology"
}